#1 Clinical Trials Search in Europe

Fosfomycin

Fosfomycin is an antibiotic that has gained attention in recent clinical trials for its potential in treating various bacterial infections. This article examines the use of fosfomycin in different clinical settings, including urinary tract infections, prosthetic joint infections, and febrile neutropenia. We’ll explore its efficacy, safety, and comparison to other antibiotics across multiple studies.

Table of Contents

What is Fosfomycin?

Fosfomycin is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called phosphonic acid derivatives. Fosfomycin is available under several brand names, including Monuril, Furabid, and Selexid[1]. This antibiotic has been in use for many years and is considered an important treatment option, especially as bacteria become resistant to other common antibiotics.

How Fosfomycin Works

Fosfomycin works by inhibiting bacterial cell wall synthesis. Specifically, it disrupts the formation of peptidoglycan, an essential component of bacterial cell walls[2]. By interfering with this process, fosfomycin effectively kills bacteria, making it a bactericidal antibiotic. This mechanism of action is different from many other antibiotics, which is one reason why fosfomycin remains effective against some bacteria that have become resistant to other treatments.

Conditions Treated with Fosfomycin

Fosfomycin is primarily used to treat the following conditions:

  • Urinary Tract Infections (UTIs): This is the most common use for fosfomycin. It’s particularly effective for uncomplicated lower urinary tract infections, also known as cystitis[3].
  • Bacterial Infections: Fosfomycin can be used to treat various bacterial infections, especially those caused by multidrug-resistant pathogens[4].
  • Febrile Neutropenia: This is a condition where patients have a fever and an abnormally low number of neutrophils (a type of white blood cell). Fosfomycin is being studied for preventing this condition in patients with certain blood cancers[5].
  • Prosthetic Joint Infections: Research is ongoing to evaluate fosfomycin’s effectiveness in treating infections associated with artificial joints[6].

Forms and Dosages of Fosfomycin

Fosfomycin is available in several forms:

  • Oral powder (sachets): This is the most common form for treating UTIs. It’s typically given as a single 3-gram dose[7].
  • Oral capsules: Some studies are investigating the use of 500 mg or 700 mg capsules taken multiple times a day[5].
  • Intravenous (IV) solution: This form is used for more severe infections or in hospital settings. Dosages can range from 6 to 24 grams per day, divided into multiple doses[4].

The exact dosage and duration of treatment will depend on the specific condition being treated and the patient’s individual factors.

Effectiveness of Fosfomycin

Fosfomycin has shown effectiveness in treating various bacterial infections, particularly urinary tract infections. Its unique mechanism of action makes it effective against many bacteria that have become resistant to other antibiotics. However, its effectiveness can vary depending on the specific bacteria causing the infection and the site of infection.

For uncomplicated UTIs, fosfomycin is often compared to other antibiotics like nitrofurantoin. Some studies suggest that a single dose of fosfomycin might be slightly less effective than a 5-day course of nitrofurantoin, but more research is needed to confirm this[2]. Ongoing research is exploring whether multiple doses of fosfomycin might improve its effectiveness while still maintaining the convenience of a short treatment course.

Side Effects and Safety

Fosfomycin is generally considered safe, with a low risk of allergic reactions. However, like all medications, it can cause side effects. The most common side effects include:

  • Diarrhea
  • Nausea
  • Headache
  • Dizziness
  • Vaginitis (inflammation of the vagina)
  • Abdominal pain

Most of these side effects are mild and self-limiting, meaning they resolve on their own[2]. Serious side effects are rare but can include severe allergic reactions. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.

Ongoing Research on Fosfomycin

Several clinical trials are currently underway to further investigate the use of fosfomycin:

  • Comparing different dosing regimens of fosfomycin for treating UTIs[2].
  • Evaluating fosfomycin’s effectiveness in preventing infections in patients with blood cancers[5].
  • Studying the use of intravenous fosfomycin for treating prosthetic joint infections[6].
  • Investigating the pharmacokinetics (how the drug moves through the body) of intravenous fosfomycin, particularly its penetration into lung tissue[4].

These ongoing studies aim to optimize the use of fosfomycin and potentially expand its applications in treating various bacterial infections.

Aspect Details
Types of Infections Studied Urinary tract infections, prosthetic joint infections, febrile neutropenia prevention
Administration Methods Oral (single dose or short course), Intravenous (for severe infections)
Comparator Antibiotics Nitrofurantoin, Ciprofloxacin
Key Advantages Shorter treatment duration, effective against resistant bacteria
Common Side Effects Gastrointestinal disturbances (diarrhea, nausea)
Ongoing Research Focus Optimal dosing, efficacy in various infections, safety profile

FAQ

  • What is fosfomycin and how does it work? Fosfomycin is an antibiotic that works by inhibiting bacterial cell wall synthesis. It's effective against many Gram-positive and Gram-negative bacteria, including some antibiotic-resistant strains.
  • In which types of infections is fosfomycin being studied? Clinical trials are investigating fosfomycin for various infections, including urinary tract infections (UTIs), prosthetic joint infections, and as a preventive measure for febrile neutropenia in cancer patients.
  • How is fosfomycin typically administered? Fosfomycin can be given orally or intravenously. Oral forms often involve a single dose or short course, while intravenous administration may be used for more severe infections.
  • How does fosfomycin compare to other antibiotics in clinical trials? Studies are comparing fosfomycin to antibiotics like nitrofurantoin and ciprofloxacin. Results vary, but fosfomycin often shows comparable efficacy with the advantage of shorter treatment durations in some cases.
  • What are the potential side effects of fosfomycin? Common side effects may include gastrointestinal disturbances like diarrhea and nausea. Serious side effects are rare, but safety profiles are being closely monitored in clinical trials.

Ongoing Clinical Trials on Fosfomycin

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on GM-CSF, Fosfomycin, and Metronidazole for Treating Pouchitis in Ulcerative Colitis Patients Post-Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on MBK-01 and Drug Combination for Treating Patients with Recurrent Diverticulitis

    Recruiting

    2 1 1 1
    Investigated drugs:
    Spain

  • Study of intraperitoneal fosfomycin, metronidazole and molgramostim treatment in patients with multi-quadrant peritonitis during abdominal surgery

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Fosfomycin for Treating Acute Bacterial Prostatitis in Patients with Multidrug-Resistant E. coli

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Fosfomycin: An antibiotic that inhibits bacterial cell wall synthesis, effective against various Gram-positive and Gram-negative bacteria.
  • Urinary Tract Infection (UTI): An infection affecting any part of the urinary system, including kidneys, bladder, and urethra.
  • Prosthetic Joint Infection (PJI): An infection occurring around a joint replacement implant, often requiring specialized antibiotic treatment.
  • Febrile Neutropenia: A condition characterized by fever and an abnormally low number of neutrophils (a type of white blood cell), often seen in cancer patients undergoing chemotherapy.
  • Bactericidal: Capable of killing bacteria, as opposed to just inhibiting their growth.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible growth of a bacterium.
  • Clinical Efficacy: The ability of a treatment to produce a desired effect under real-world clinical conditions.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease associated with the use of a medical treatment.
  • Randomized Controlled Trial: A study design where participants are randomly assigned to different treatment groups to compare outcomes.

References

  1. https://clinicaltrials.gov/study/NCT04959331
  2. https://clinicaltrials.gov/study/NCT05254808
  3. https://clinicaltrials.gov/study/NCT06518291
  4. https://clinicaltrials.gov/study/NCT03910673
  5. https://clinicaltrials.eu/trial/study-comparing-fosfomycin-and-ciprofloxacin-for-preventing-fever-in-patients-with-acute-leukemia-after-chemotherapy-or-stem-cell-transplant/
  6. https://clinicaltrials.gov/study/NCT05211011
  7. https://clinicaltrials.gov/study/NCT01966653